rs1799817 — INSR His1085His

The Insulin Receptor's Silent Gatekeeper — INSR His1085His

The insulin receptor is the master switch for glucose metabolism. When insulin binds to its extracellular alpha subunit, it triggers a conformational change that activates the intracellular beta subunit's tyrosine kinase domain — initiating a cascade that opens glucose transporters, suppresses glucose production, and directs energy storage. Variants in the tyrosine kinase domain, even synonymous ones that don't change the amino acid sequence, can subtly alter how this switch operates.

rs1799817 (His1085His) is a C→T transition on the coding strand of exon 17, which encodes part of the catalytic kinase domain. On the plus strand used by genome files, the alleles are G (reference) and A (alternate). Despite producing no amino acid change, this variant sits adjacent to the ATP-binding site critical for receptor autophosphorylation — the event that initiates insulin signaling.

The Mechanism

Synonymous variants in coding regions were long assumed to be functionally inert. More recently, evidence has accumulated that so-called silent polymorphisms¹¹ silent polymorphisms
Silent variants can influence mRNA secondary structure, codon usage, and exon splicing enhancer sequences — all of which alter the efficiency of protein translation and the final level of functional receptor at the cell surface. can perturb mRNA processing, codon translation efficiency, or splicing enhancer elements²² splicing enhancer elements
Exonic splicing enhancers (ESEs) are short consensus sequences within exons that recruit splicing factors. A synonymous SNP that disrupts an ESE can cause exon skipping or intron retention, potentially altering the reading frame or domain composition of the final protein. within exon 17.

The H1085 position is located near the ATP-binding cleft of the INSR tyrosine kinase domain. While the substitution of one histidine codon for another (CAC→CAT) does not change the amino acid, it may alter local mRNA secondary structure and translational speed, potentially affecting the co-translational folding of the kinase domain. The downstream consequence — proposed in multiple studies — is increased serine phosphorylation of the receptor, a modification that competitively inhibits tyrosine autophosphorylation and blunts post-receptor insulin signaling.

The Evidence

The most consistent finding across studies is an association between the A allele (coding-strand T; rs1799817) and PCOS risk, particularly in lean women.

A 2020 Saudi Arabian case-control study³³ 2020 Saudi Arabian case-control study
Alnaaim et al. RS1799817 in INSR associates with susceptibility to polycystic ovary syndrome. Int J Clin Pract. 2020. PMID:33033446 (126 PCOS cases, 118 controls) found the T allele significantly enriched in PCOS women (allele frequency 0.306 vs. 0.174 in controls, p<0.001). The relative risk was 2.82 in heterozygotes, with the association most pronounced in lean PCOS women who had elevated HOMA-IR.

An Indian cohort study (Vasan et al. 2020⁴⁴ Vasan et al. 2020
Vasan et al. Association of GWAS identified INSR variants with PCOS in Indian women. Int J Biol Macromol. 2020. PMID:31837364) showed OR 11.8 (95% CI 6.3–22.3) for PCOS among T allele carriers (n=240), with significantly higher serum insulin and testosterone levels in the risk-allele group.

Earlier work by Mukherjee et al. 2009⁵⁵ Mukherjee et al. 2009
Mukherjee et al. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with PCOS. Eur J Endocrinol. 2009. PMID:19211708 showed that C/T heterozygotes in lean PCOS women had significantly higher HOMA-IR and free androgen index compared to C/C homozygotes — the key functional connection between the INSR variant and the PCOS phenotype.

However, the picture is not uniform. A 2021 meta-analysis⁶⁶ 2021 meta-analysis
Cao et al. Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population. J Assist Reprod Genet. 2021. PMID:34403018 pooling 3,635 participants across 15 Asian studies found no statistically significant association in the overall pooled analysis — though individual studies in Korean and Chinese subsets showed significant effects. This heterogeneity likely reflects differences in PCOS diagnostic criteria, BMI stratification, and population structure across studies.

Practical Actions

The primary clinical implication of this variant is for women in whom standard PCOS screening may be warranted. The variant is associated most strongly with insulin resistance in lean women — a presentation of PCOS that is frequently missed because insulin resistance is often assumed to require obesity.

Fasting insulin and HOMA-IR⁷⁷ HOMA-IR
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) = fasting insulin (µIU/mL) × fasting glucose (mmol/L) ÷ 22.5. Values above 2.0-2.5 are typically considered indicative of insulin resistance. monitoring provides a non-invasive window into whether receptor signaling is impaired, regardless of body weight.

Interactions

rs1799817 is in moderate linkage disequilibrium with rs2059807, another INSR variant that tags the same GWAS signal identified in Han Chinese populations. Carrying both risk alleles compounds the signal at the INSR locus. The INSR locus interacts with the THADA locus (rs13429458) in PCOS GWAS — these represent independent pathways (insulin receptor signaling vs. Ca²⁺ channel/thyroid adenoma-associated gene), and women with risk variants at both loci show additive increases in metabolic syndrome prevalence.